1. Swartz MN. Clinical practice. Cellulitis. N Engl J Med. 2004. 350:904–912.
2. Morris AD. Cellulitis and erysipelas. Clin Evid (Online). 2008. pii:1708.
3. Pasternack MS, Swartz MN. Mandell GL, Bennett JE, Dolin R. Cellulitis, necrotizing fascitis, and subcutaneous tissue infections. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2009. 7th ed. Philadelphia: Saunders Elsevier;1289–1312.
4. Baddour LM, Bisno AL. Recurrent cellulitis after saphenous venectomy for coronary bypass surgery. Ann Intern Med. 1982. 97:493–496.
Article
5. Dankert J, Bouma J. Recurrent acute leg cellulitis after hysterectomy with pelvic lymphadenectomy. Br J Obstet Gynaecol. 1987. 94:788–790.
Article
6. Simon MS, Cody RL. Cellulitis after axillary lymph node dissection for carcinoma of the breast. Am J Med. 1992. 93:543–548.
Article
7. Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O, Sassolas B, Guillaume JC, Grob JJ, Bastuji-Garin S. Risk factors for erysipelas of the leg cellulitis casecontrol study. BMJ. 1999. 318:1591–1594.
Article
8. Chartier C, Grosshans E. Erysipelas. Int J Dermatol. 1990. 29:459–467.
Article
9. Chartier C, Grosshans E. Erysipelas: an update. Int J Dermatol. 1996. 35:779–781.
Article
10. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan EL, Montoya JG, Wade JC. Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005. 41:1373–1406.
Article
11. Perl B, Gottehrer NP, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis. 1999. 29:1483–1488.
Article
12. Woo PC, Lum PN, Wong SS, Cheng VC, Yuen KY. Cellulitis complicating lymphoedema. Eur J Clin Microbiol Infect Dis. 2000. 19:294–297.
Article
13. Hook EW 3rd, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med. 1986. 146:295–297.
Article
14. Duvanel T, Auckenthaler R, Rohner P, Harms M, Saurat JH. Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med. 1989. 149:293–296.
Article
15. Kielhofner MA, Brown B, Dall L. Influence of underlying disease process on the utility of cellulitis needle aspirates. Arch Intern Med. 1988. 148:2451–2452.
Article
16. Sachs MK. The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults. Arch Intern Med. 1990. 150:1907–1912.
Article
17. Bernard P, Bedane C, Mounier M, Denis F, Catanzano G, Bonnetblanc JM. Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol. 1989. 125:779–782.
Article
18. Lee JY, Park SD. A study for improvement of the positive culture rate using skin biopsy specimens in patients with cellulitis. Korean J Dermatol. 2007. 45:134–139.
19. Hahn SH, Yang BK, Kim CH, Ahn TW, Suh SK. Cellulitis in young adults. J Korean Orthop Assoc. 1998. 33:614–619.
Article
20. Grayson ML, McDonald M, Gibson K, Athan E, Munckhof WJ, Paull P, Chambers F. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults. Clin Infect Dis. 2002. 34:1440–1448.
Article
21. Chan JC. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology. Adv Ther. 1995. 12:139–146.